MedTrace Logo

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

NCT03076671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 783

Last updated 2021-05-14

No results posted yet for this study

Summary

This is a two-center (University of Colorado, University of California San Francisco) community-based comparative effectiveness study of outpatient palliative care for Parkinson's disease (PD) and related disorders (progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple systems atrophy (MSA), Lewy Body Dementia (LBD). In September 2018, the study was amended to also include Alzheimer's disease (AD) and related disorders (Frontotemporal Dementia (FTD), Primary Progressive Aphasia (PPA), Vascular Dementia). It will utilize a randomized stepped-wedge design to compare patient and caregiver outcomes between usual care in the community versus usual care augmented by palliative training and telemedicine support to provide other resources (e.g. social work).

Conditions

  • Parkinson Disease
  • Parkinsonism
  • Lewy Body Disease
  • Supranuclear Palsy, Progressive
  • Parkinsonism Vascular
  • Multiple System Atrophy
  • Corticobasal Degeneration
  • Alzheimer Disease
  • Frontotemporal Dementia
  • Primary Progressive Aphasia
  • Vascular Dementia

Interventions

BEHAVIORAL

Palliative Care

Palliative care training for community neurologists and use of telemedicine for team-based support of patients

Sponsors & Collaborators

Principal Investigators

  • Benzi M Kluger, MD, MS · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03076671 on ClinicalTrials.gov